#MEAction RFI Poll Report (Part 3 of 3)

This is the third article in our series on the #MEAction RFI polling data.  Click here for Part I and here for Part II.

Clinical and Research Testing

06.Testing
Figure 1
Perhaps unsurprisingly given Davis’s recent progress, metabolomics were what patients believed ME research needs to progress swiftly; two-day exercise testing was rated as less important, perhaps due to concerns about damage to patients.

Potential Treatments

07.Treatments
Figure 2
Treatments that have an effect on cellular respiration were rated as most important by stakeholders.
Multiple studies have found errors in cellular respiration and general mitochondrial dysfunction in ME patients, including:

  • Disordered glycolysis
  • Coenzyme Q-10 deficiency correlated to cognitive dysfunction
  • Abnormality in the structure of mitochondria, including mitochondrial degeneration, atrophy of type II fibers, and fusion and branching of mitochondrial cristae
  • Preliminary evidence of disordered citric acid cycle

Given the complexity of energy metabolism, cellular respiration may be affected at different junctures of different pathways in different patients; this may be a source of patient subgroups. It is urgent that the NIH study energy metabolism dysfunction in ME an CFS patients and test the efficacy of replacement therapies.
Stakeholders also rated Rituximab and anti-virals as very important, while the indictment of CBT and GET therapies as practiced by the BPS school is clear.

Epidemiology and Medical Hypotheses

08. Hypotheses and Misc
Figure 3
Contrasting recovered or near-recovered patients with patients who progressively decline

Stakeholders prioritized understanding why some patients relapse-remit, some patients grow progressively worse, and others seem to regain or nearly regain their previous level of function – what is different about these 5% of adults who recover?

Children with ME

There are only a small handful of studies on adolescents or children with ME.

The Vagus Nerve Hypothesis

The vagus nerve hypothesis states that it is an infection of the vagus nerve itself that causes an exaggerated inflammatory response which results in the symptoms of ME. The vagus nerve signals the body to rest in the case of a peripheral infection, but an infection of the nerve itself would amplify this signal.

Genetics of families where ME is prevalent

27.96% of #MEAction survey respondents stated they had at least one family member with ME or CFS (n=1266). It may be that a particular, heritable immunological phenotype can predispose members of the population to developing ME or CFS.
Thank you again for your participation in the #MEAction RFI — you made it possible for us to turn in a thorough report describing the priorities of 1800 stakeholders!  Every bit of advocacy helps move us forward.
Save
Save
Save
Save
Save
Save
Save
Save
Save
Save
Save
Save
Save
Save

Facebook
Twitter
WhatsApp
Email

3 thoughts on “#MEAction RFI Poll Report (Part 3 of 3)”

    1. Thanks to everyone who participated! I keep reminding myself that I should publish the larger version, now that the #MEAction one is out! However, a lot happening as we approach the protests…

Comments are closed.

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top